Notice on Convening the 2025 Annual General Meeting
Filed with SSE · · 8 pages · Chinese
Suzhou Fengbei Biotech Stock Co., Ltd. on 6ix
Earlier from Suzhou Fengbei Biotech Stock
- Announcement on Redemption at Maturity of Partial Idle Raised Funds Used for Cash Management
- Announcement on Abnormal Fluctuations in Stock Trading
- Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business License
- Announcement on Conducting Forward Foreign Exchange Settlement and Sale and Other Foreign Exchange Derivatives Transactions
Later from Suzhou Fengbei Biotech Stock
- Announcement on Opening Special Settlement Account for Cash Management of Raised Funds
- Announcement on Circulation of Partial Restricted Shares in Offline Placement of Initial Public Offering
- Report for Q1 2026
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Convening Performance Briefing for 2025 and Q1 2026
Follow Suzhou Fengbei Biotech Stock into a list and get an email when it puts out news.
Follow Suzhou Fengbei Biotech Stock